795318

Alexion Pharmaceuticals, Inc. — FEI 3006031727

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 17, 2012
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
New Haven, CT (United States)

Citations

IDCFRDescription
111221 CFR 211.25(a)Training--operations, GMPs, written procedures
241921 CFR 211.198(a)Complaint Handling Procedure
261821 CFR 211.198(b)(1)Complaint Record required information